Internal Medicine, Pulmonary Disease · Salem, VA
NPI
1407827231
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
1802 Braeburn Dr
Salem, VA, 24153
Phone (540) 772-3540
Groups this clinician bills Medicare through
Medicare paid, 2024
$119K
1,679 services
Medicare patients, 2024
524
Average age 75
Drug cost, 2024
$2.3M
4,233 prescriptions
Company payments, 2025
$3,416
From 25 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by James Witten Jr. was code 99214 (office e&m - established), 868 times for 367 patients. In total James Witten Jr. billed 1,679 services in 21 codes, and Medicare paid $119K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-12-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 868 | 367 | $92.74 | $80K |
| 99232 Hospital E&M - Subsequent | Facility | 274 | 79 | $58.80 | $16K |
| 94729 Pulmonary Function Testing | Facility | 99 | 94 | $6.45 | $638 |
| 94726 Pulmonary Function Testing | Facility | 91 | 86 | $8.82 | $803 |
| 99204 Office E&M - New | Office | 91 | 91 | $122.23 | $11K |
| 94060 Pulmonary Function Testing | Facility | 78 | 76 | $7.62 | $595 |
| 94010 Pulmonary Function Testing | Facility | 47 | 44 | $5.87 | $276 |
| 99223 Hospital E&M - Initial | Facility | 39 | 39 | $132.60 | $5,171 |
| 94010 Pulmonary Function Testing | Office | 22 | 21 | $20.48 | $451 |
| 94060 Pulmonary Function Testing | Office | 18 | 18 | $16.08 | $289 |
| 99213 Office E&M - Established | Office | 11 | 11 | $56.78 | $625 |
By year: 2022 $109K for 1,786 services; 2023 $113K for 1,651 services; 2024 $119K for 1,679 services.
Medicare prescription drug claims, 2024
In 2024, the drug James Witten Jr. prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 1,000 prescriptions and refills. In total James Witten Jr. wrote 4,233 Medicare prescriptions that cost $2.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 1,000 | 1,264 | 171 | $799K |
| Prednisone Generic | 471 | 528 | 157 | $2,011 |
| Montelukast Sodium Generic | 461 | 830 | 105 | $2,990 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 401 | 496 | 131 | $9,343 |
| Azithromycin Generic | 174 | 212 | 58 | $1,790 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 153 | 175 | 30 | $109K |
| Arnuity Ellipta Fluticasone Furoate | 146 | 150 | 53 | $35K |
| Breo Ellipta Fluticasone/Vilanterol | 131 | 165 | 24 | $64K |
| Symbicort Budesonide/Formoterol Fumarate | 102 | 154 | 30 | $35K |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 89 | 133 | 17 | $62K |
| Theophylline Er Theophylline Anhydrous | 74 | 96 | 19 | $4,720 |
| Fluticasone Propionate Hfa Fluticasone Propionate | 73 | 95 | 30 | $22K |
| Doxycycline Hyclate Generic | 72 | 80 | 29 | $1,026 |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 58 | 64 | Under 11 | $30K |
| Spiriva Respimat Tiotropium Bromide | 55 | 69 | 12 | $36K |
Brand drugs: 2,395 claims; generic drugs: 1,838 claims; opioid claims: 17.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid James Witten Jr. $3,416 ($3,416 in general payments such as food, travel and fees) from 25 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $816.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 27 | $816 |
| GlaxoSmithKline, LLC. GSK | 21 | $355 |
| Mallinckrodt Hospital Products Inc. | 8 | $323 |
| Regeneron Healthcare Solutions, Inc. REGN | 16 | $258 |
| Genzyme Corporation SNY | 13 | $224 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $210 |
| Actelion Pharmaceuticals US, Inc. JNJ | 4 | $155 |
| ANI Pharmaceuticals, Inc. ANIP | 8 | $150 |
| Insmed, Inc. INSM | 5 | $111 |
| Sanofi-Aventis U.S. LLC SNY | 1 | $98.99 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.